Telegram-
Loading indices

KOSDAQ · 144510

GC CELL

Market cap₩218B
PERN/A
PBR1.12×
Foreign ownership2.88%

Pension summary

as of Oct 19
streakNone
5D₩0M
20D₩0M
60D₩0M
Foreign 20D-₩470M
Inst. 20D-₩10M

Pension daily net buy

-

Cumulative net buying by investor

-
선택 기간의 net buy Total · ₩100M
DateClosePension fundsForeignInstitutionsRetail
10/1913,690–+₩30M₩0M-₩30M
10/1613,480–+₩80M+₩10M-₩90M
10/1512,810–-₩70M₩0M+₩40M
10/1413,470–-₩30M₩0M+₩30M
10/1313,550–+₩10M₩0M-₩10M
10/1213,920–-₩70M-₩10M+₩80M
10/814,690–+₩20M+₩10M-₩30M
10/715,080–₩0M-₩10M+₩10M
10/614,920–+₩40M-₩10M-₩20M
10/214,540–₩0M+₩10M-₩10M

Discussion

Google-verified members · return since posting
0/300

  1. Loading

세력 매집

last 60 trading days · Oct 19
Foreign 60D−₩1.2B
Pension funds 60D₩0M
세력 Avg. cost13,811
vs. cost Close-0.9%

Foreign+Pension funds Total 시총의 -0.5%, 60D price 폭 19%·Chg +5.0%. 세력 Avg. cost net buy한 날의 Avg 매수단가로 낸 est.치예요.

세력 매집 구간 All →

ETF

ETFs holding it in their top 10 · recent changes

10/08 이후 큰 ETF 변화는 없어요

All ETF index changes →

Recent filings

DART
  1. Loading

Broker price targets

Recent 1Y

Recent reports

  1. NDR 후기: 세포치료제 포트폴리오 Zoom inMirae Asset Securities · 06/18
  2. 세포치료제 푸카소 상업화와 NK 파이프라인 모멘텀이 동시에 열린다Korea IR Council · 04/29
  3. KRX 세포유전자치료제의 선두주자Korea IR Council · 11/12

Latest report per broker in the past year · Source: Naver Securities Research, Hankyung Consensus · Analyst names masked

Same sector

  1. Caregen
  2. CHA Biotech
  3. KBH
  4. HEM Pharma
  5. COSMAX bti
  6. DXVX

GC CELL summary

GC CELL (144510). Pension funds last 20 trading days ₩0M. Market cap ₩218B, PER N/A, PBR 1.12×. Pension flows are based on Korea Exchange investor statistics, for reference only.